Holen Sie sich die Stockscreener-App
41.53
1.94%
-0.82
Vorhandelsmarkt:
42.34
0.81
+1.95%
Schlusskurs vom Vortag:
$42.35
Offen:
$41.34
24-Stunden-Volumen:
14.19M
Relative Volume:
0.39
Marktkapitalisierung:
$9.04B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
60.19
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
-8.42%
1M Leistung:
-33.61%
6M Leistung:
-7.90%
1J Leistung:
+181.94%
1-Tages-Spanne:
$40.78
$42.14
1-Wochen-Bereich:
$40.78
$45.92
52-Wochen-Spanne:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
41.53 | 9.57B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
157.99 | 367.85B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
63.54 | 154.96B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
84.39 | 67.95B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
128.84 | 42.85B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
20.78 | 39.74B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
Hers Health Inc. in sector analysis2025 Institutional Moves & Long-Term Safe Investment Ideas - Newser
HIMS' Personalized Wellness Platform Expands Preventive Care Access - sharewise.com
Hers Health Inc. holdersBond Market & Long-Term Growth Portfolio Plans - Newser
Hers Health Inc. reversing from oversold territoryLayoff News & Accurate Buy Signal Notifications - Newser
Hers Health Inc.Portfolio Update Summary & AI Driven Stock Price Forecasts - Newser
Hims & Hers Health: Still Undervalued (NYSE:HIMS) - Seeking Alpha
Hers Health Inc. stock trend forecastRisk Management & Reliable Volume Spike Trade Alerts - Newser
Hers Health Inc. bounce back from current support2025 Price Targets & AI Enhanced Trading Signals - Newser
Insider Moves: Datadog, Hims & Hers, Opendoor, Texas Instruments, Vertiv - TipRanks
Hers Health Inc.’s reversalGap Down & Stock Timing and Entry Methods - Newser
Hims & Hers: The Dominant Health Platform Of The Future (NYSE:HIMS) - Seeking Alpha
Real time social sentiment graph for HIMSNew Guidance & Safe Entry Trade Reports - Newser
Hers Health Inc. stock entering bullish territoryTrade Exit Report & Growth Focused Entry Reports - Newser
Hims & Hers Climbs to 102nd in Market Activity With $790M Volume as Insider Sales and Mixed Earnings Spark Doubts - AInvest
Hims & Hers Health Insider Selling: Signal of Distrust or Strategic Rebalancing? - AInvest
Hers Health Inc. in the next 30 daysPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - The Globe and Mail
Hims & Hers Health Stock Plunges 2.95% as Trading Volume Falls 32% to $890M and Drops to 67th in Activity - AInvest
Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Hims & Hers Scales Growth Through Subscriptions and Care Expansion - sharewise.com
Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder - ca.finance.yahoo.com
Hims & Hers Health Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Hers Health Inc. stock performanceQuarterly Trade Review & Daily Growth Stock Investment Tips - Newser
Hims & Hers Stocks: Join the Pharma Boom? - StocksToTrade
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Disruption and Recent Challenges - Quiver Quantitative
Hims & Hers Health Surges 5.15% on Intraday Rally—What’s Fueling the Momentum? - AInvest
Hims & Hers' Resilience Amid GLP-1 Market Shifts: Short-Term Volatility vs. Long-Term Personalized Care Positioning - AInvest
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
Hims & Hers: Navigating Short-Sellers and Regulatory Storms in the DTC Healthcare Sector - AInvest
Levi & Korsinsky Helps Shareholders SueWallSt After Hims & Hers Health, Inc. Stock Drops - Stockhouse
Hims & Hers Health: Navigating Regulatory Storms and Rebuilding a Growth Narrative - AInvest
Hims & Hers: A Case Study in Governance and Partnership Risks in the Digital Health Sector - AInvest
Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Benzinga
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers - Benzinga
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
DEADLINE ALERT for HIMS, IRBT, and CNC: The Law Offices of - GlobeNewswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before August 25, 2025 to Discuss Your RightsHIMS - WV News
Is Regulatory Scrutiny and Novo Nordisk Partnership Loss Changing the Investment Case for Hims & Hers Health (HIMS)? - Yahoo Finance
Top 3 US Digital Health Stocks That are Leading the Healthcare Revolution - The Smart Investor
Investors in Hims & Hers Health, Inc. (HIMS): Protect Your RightsContact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Hims & Hers Health, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsHIMS - MarketScreener
Hers Health Inc. price bounce be sustainableMarket Growth Summary & AI Driven Stock Price Forecasts - Newser
Securities Class Action Risks in Digital Health Firms: A Deep Dive into Hims & Hers Health, Inc. - AInvest
Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - GlobeNewswire Inc.
HIMS DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS - GlobeNewswire Inc.
HIMS Deadline: HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - PR Newswire
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):